<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): January 2, 2001
----------------
3-DIMENSIONAL PHARMACEUTICALS, INC.
---------------------------------------------------------
(Exact Name of Registrant Specified in Charter)
Delaware 000-30992 23-2716487
--------------------- --------- ----------
(State or Other (Commission File (I.R.S. Employer
Jurisdiction of Number) Identification No.)
Incorporation)
665 Stockton Drive
Exton, Pennsylvania 19341
------------------------------------------------ -------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (610) 458-8959
----------------------
Not Applicable
-----------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE>
Item 5. Other Events.
On January 2, 2001, 3-Dimensional Pharmaceuticals, Inc. issued the
following press release attached hereto as Exhibit 99.
Item 7. Financial Statements and Exhibits.
(c) Exhibits
99 Press release dated January 2, 2001.
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
as amended, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
3-DIMENSIONAL PHARMACEUTICALS, INC.
By /s/ Scott M. Horvitz
----------------------------------------------
Scott M. Horvitz
Vice President, Finance and Administration
Dated: January 2, 2001
<PAGE>
EXHIBIT INDEX
Exhibit
Number Description
------ -----------
99 Press Release dated January 2, 2001
